Neuropsychological, behavioral, and quality-of-life outcomes in children and adolescents with sickle cell disease treated with nonmyeloablative matched sibling donor hematopoietic cell transplantation: A case series.
Taryn B Fay-McClymontDania A MonagelGurpreet SinghFiona SchulteBrian L BrooksWilliam S MacAllisterNaddley DésiréAleksandra MineykoMarsha VassermanMichael T LeakerTony H TruongRavi ShahVictor A LewisKeith Owen YeatesGregory M T GuilcherPublished in: Pediatric blood & cancer (2022)
Neuropsychological functioning in a sample of children and adolescents treated uniformly with NMA MSD HCT remained stable or improved in most cognitive domains, and improvements in quality of life and family functioning were observed.